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Genomic DNA for Na,K-ATPase a, subunit was obtained from libraries of horse kidney genomic DNA in Charon 4A 
and in EMBL3 bacteriophages by screening with the full sized cDNA probe of the ai subunit of rat Na,K-ATPase as 
probe. The gene spans 30 kb and consists of 23 exons and 22 intervening sequences. Intron-exon boundaries were ana- 
lyzed. The protein-coding nucleotide sequence ncodes 1016 amino acids with an M, of 112 264. The putative amino 
acid sequence of horse a, is 9697% homologous to those of other mammalian species. 
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1. INTRODUCTION 
Na,K-ATPase is the plasma membrane protein 
responsible for active transport of Na+ and K+ 
across the cell membrane in most animal cells. It 
consists of at least two subunits, (Y and 6. The 
primary structures deduced from cDNAs of cyl 
subunits from rat [l-3], human [4], sheep IS], pig 
[6], chicken [7] and Torpedo [8] are similar to each 
other. Isoforms of the catalytic unit, LYZ (cu’) [1,3] 
and CYY~ @III) [ 1,2], in rat brain have been identified 
by cDNA cloning and sequencing. Expression of 
isoform genes has been studied by determining the 
mRNA levels in various tissues and in different 
stages of development [3,9- 151. Multiplicity of 
human Na,K-ATPase genes encoding isoforms has 
been suggested [16,17] on the basis of studies on 
genomic DNA. Four genes including al and CYZ 
have been identified by screening a human 
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leucocyte genomic library [ 171. In a genomic 
library from human placenta, 5 genes including (~1, 
CYZ and (~3 have been isolated [16]. Isoforms are 
products of separate genes and the total length of 
an cy gene is reported to be 20 to 25 ,kb [ 171. Most 
of the intron-exon boundaries of the a3 subunit of 
human gene have been analysed [18]. Many of the 
introns are located at the boundaries of functional 
domains. 
Horse kidney Na,K-ATPase has been used to 
determine the minimal structural unit, C$ 
monomer, possessing enzyme activity [19,20] and a 
monoclonal antibody against the horse kidney LYI 
subunit which recognizes an extracellular domain 
has been prepared and characterized [21]. 
However, the primary structure of horse Na,K- 
ATPase has not been studied. We have obtained 
the genomic DNA that corresponds to the cyi 
subunit. The present study was undertaken to 
determine the complete intron-exon organization 
of LYI subunit DNA of horse Na,K-ATPase and at 
the same time to analyse the deduced amino acid 
sequence in relation to the characteristics of the 
enzyme. 
Published by Eisevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 91 
Volume 250, number 1 FEBS LETTERS June 1989 
2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
2.1. Construction of genomic library 
Genomic DNA was isolated from horse kidney outer medulla 
[22]. The first library was made as follows. The DNA fragments 
of 12-22 kb in length prepared by partial EcoRI digestion and 
elution from agarose gels were ligated to Charon 4A arms and 
packaged using packaging extract (Amersham). Amplification 
was done in LE392 cells. Approximately 3 x lo6 plaques 
transferred to filters were screened with cloned full size cDNA 
of the rat brain crl subunit (kidney type) of Na,K-ATPase [2] as 
probe. Then the hybridization-positive plaques were further 
screened with a synthetic oligonucleotide probe GGCTGGGT- 
GGAGAAGGAGACCTACTACTAG corresponding to the C- 
terminus of a-subunit of sheep kidney Na,K-ATPase [5]. The 
second library was made of 9-23 kb Sau3AI fragments in 
EMBL3 lambda replacement vector. DNA was packaged using 
Gigapack Gold (Stratagene) and the phages were grown in 
P2392 cells. LE392 cells were used for plaque purification. Ap- 
proximately 3 x lo6 plaques were screened, without amplifica- 
tion, using as probe a 0.5 kb EcoRI-HincII fragment from near 
the 5’-end of clone 6 (designated as probe 1 in fig.1) and also 
using a 215 bp PslI-HaeIII fragment coding for the amino- 
terminus of rat LYE subunit (nucleotide number -45 to 170 [2]) 
to search for genomic DNA containing amino-terminal exons. 
A plaque containing insertion DNA spanning from clone 6 to 
clone 41 was probed with a 0.5 kb HincII-XbaI fragment of 
horse genomic DNA excised from the carboxyl-terminus of 
clone 6 (probe 2 in fig.1). 
3.1. Organization of the gene for Na,K-A TPase CYI 
subunit 
Screening of approximately 3 x lo6 plaques of 
recombinant Charon 4A bacteriophages with a rat 
cDNA of the entire coding region of the cyl subunit 
as probe yielded 33 positive clones. Eighteen clones 
had identical restriction profiles (called clone 6). 
One clone, designated clone 41, hybridized with an 
oligonucleotide corresponding to the C-terminal 
probe. Clone 6 carried the majority of exons of the 
LYE subunit gene of Na,K-ATPase. The second gene 
library in EMBL3 was screened with probe 1 (fig. 1) 
and 5 clones were obtained. Among them clone 
107 was the longest extending to 5’-direction. By 
probing the second library with probe 2 (fig.l), 
clone 42, which overlapped with both clone 6 and 
clone 41, was obtained. The restriction map of the 
gene was shown in fig. 1. Total length of the gene 
is approximately 30 kb. 
3.2. Nucleotide sequences 
2.2. Hybridization 
The synthetic probe of 30 nucleotides was 5’-end-labeled 
with [y-“P]ATP (spec. act. 25.9 TBq, 700 Ci/mmol, ICN) by 
kination and other probes were labeled with [cu-“P]dCTP (spec. 
act. 111 TBq, 3ooO: Ci/mmol, ICN) by nick-translation (nick- 
translation system or multiprime DNA labeling systems, both 
from Amersham) and passed through a Sephadex column 
(NAP-25 from Pharmacia). Hybridization of the plaques on 
nylon filters (Hybond N, Amersham) with the 30 nucleotide 
probe and with the rat (~1 amino-terminal 215 bp probe was per- 
formed at 42°C and hybridization with other probes was at 
65°C. Hybridization solution contained 6 x SSC (1 x SSC = 
150 mM NaCl and 50 mM sodium citrate), 5 x Denhardt’s 
solution (1 x Denhardt’s = 0.02% bovine serum albumin, 
0.02% polyvinylpyrrolidone and 0.02% Ficoll), 0.1% SDS, and 
1OOpg of denatured salmon sperm DNA/ml. Washings were 
performed in 2 x SSC and 0.1% SDS. Southern blot hybridiza- 
tion of phage DNAs and their subcloned DNAs was performed 
principally under the same conditions as plaque hybridization. 
2.3. Subcloning and sequencing 
Genomic DNAs in phages were analyzed by restriction map- 
ping and subcloned into pUC18 or pUC19 plasmid in E. coli 
strain JM83. DNA fragments in pUC18 were subjected to 
nucleotide sequence analysis using [cu-‘sS]thio-dCTP (spec. act. 
18.5 TBq, 500 Ci/mmol, NEN) and Sequenase (United States 
Biochemical Corporation) by the dideoxy chain termination 
method [23]. Large fragments in pUC18 or pUC19 were deleted 
from one end by use of a deletion system (Takara Shuzo) to ob- 
tain appropriate sizes for sequencing. 
Analysis of intron-exon distribution revealed 
that Na,K-ATPase gene consists of 22 intervening 
sequences and 23 exons ranging in size from 60 to 
269 basepairs. Exon 1 has 12 bp coding region and 
continues to the 5 ’ -noncoding region. As for the 
exon 23, 26 bp exon continues to 3’-region (fig.2). 
First exon which contains coding sequence for only 
4 amino acids is 10.5 kb apart from the 2nd exon, 
whereas most introns are less than 2.30 kb long. 
This large intron does not seem to contain a region 
to code for exons of any other form of Na,K- 
ATPase protein (data not shown). However, it is 
not known if any promoter sequences exist in this 
intron. All of the intron junctions are completely 
consistent with the published consensus equences 
for donor and acceptor sites [24]. Six out of 9 
splice sites, which occurred within a triplet, were 
within glycine codons. The organization of the LYJ 
subunit of the human Na,K-ATPase gene has been 
elucidated [16,18,25] for the most part except for 
the site of first intron and the splice site of the first 
intron was presented in the case of human LYZ gene 
[26]. The intron-exon arrangement in the horse CVI 
gene corresponds to that in human (~3 except that 
intron 10 in horse gene intervenes 2 bp upstream of 
that in human cy3 [ 181. The size of introns is 
variable. However, the organization of exons 
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Fig. 1. The map of horse Na,K-ATPase CYI subunit genomic DNA. Positions of exons are shown by vertical thick lines. Numbers from 
1 to 23 represent exons. Clone 6 and clone 41 were obtained from the Charon 4A library and clone 107 and clone 42 were from the 
EMBL3 library. Restriction sites of EcoRI (E), BumHI (B) and Wind111 (H) are indicated. 
seems to be conserved among species and even 
among isoforms. The horse CYI Na,K-ATPase DNA 
sequence, composed of l-23 exons which corres- 
pond to the open reading frame of cDNA, has the 
homology values, rat cyr [2] 87.9070, human (~1 [4] 
91.2%, sheep cyr [5] 90.6%, pig LYE [6] 90.9070, 
chicken ~1 [7] 80.5070, Torpedo CYI [8] 75.2%, rat 
CX~ [l] 75.6% and rat ~3 [l] 76.1%. It is interesting 
that the 5 ’ -noncoding sequence of al from horse is 
similar to those from human [4] and other species 
[7], but there is no resemblance with LYZ from 
human [26] or rat [l], or with cy3 from human [18] 
or rat [l]. The same features are: the similarity of 
those of CQ from human [26] and rat [l] and (~3 
from human [ 181 and rat [ 11, and the dissimilarities 
between isoforms in the same species, such as ~2 
[26] and LYJ [18] from human and (~1, CYZ and (~3 
from rat [ 11. This would indicate that the leader se- 
quence upstream of the first exon is common in the 
same isoform irrespective of species. There might 
be specific sequences characteristic of the 
isoforms, which are significantly related to the ex- 
pression of the genes in various tissues. 
Since the cap site of horse DNA has not been 
determined, the exact site of transcription initia- 
tion cannot be specified. The comparison of 
886 bp sequenced in horse and 318 bp of human al 
cDNA [4] in the 5 ‘-region shows the similarity of 
the sequence of about 230 bp upstream from ATG 
translation initiation site. This implies that no in- 
trons exist at least in the region of 230 bp upstream 
of ATG triplet. Sequences ihich correspond to the 
TATA box [27] or CCAAT box [28] are not discer- 
nible. GC-rich clusters, which are common to 
housekeeping genes [29], are conspicuous in the 
5 ’ -noncoding region. The sequence, CCCTCG- 
CTC, occurs twice at - 137 to - 129 and - 115 to 
- 107. These are located in the vicinity of TCC 
repeats which are sensitive to Sl nuclease [30]. The 
sequence, GGGGGCGGAG, at -406 to - 397 
coincides with the Spl promoter-binding sequence 
[31] and its inverted sequence, GAGGCGGGGG, 
is located at - 277 to - 268. The sequence GGC- 
GGAGGAGGCGG at - 232 to - 219 forms an in- 
verted repeat and this might also be related to the 
Spl promoter. The sequence at - 29 to - 18, 
CCCGGCGCCGGG, exists as a palindrome. In 
the 3 ’ -noncoding region the similarity of se- 
quences of cyl cDNAs from various species are 
characteristic [7]. The polyadenylation signal 
AATAAA was observed at 300 bp downstream 
from the stop codon. 
The LYE gene of the horse Na,K-ATPase is 
thought to represent a single gene separate from 
genes of other isoforms of the horse enzyme. As 
regards other cation-transporting ATPases, two 
isoforms of plasma membrane Ca’+-ATPase from 
rat brain are encoded on separate genes [32] like 
Na,K-ATPases. In contrast, neonatal and adult 
type isoforms are produced by the alternative splic- 
ing of the 3 ‘-region of the gene for rabbit fast 
twitch Ca’+-ATPase [33]. Further extensive 
analysis of genomic DNA of Na,K-ATPase should 
facilitate an understanding of the regulatory fac- 
tors of expression. 
3.3. Comparison of amino acid sequences 
Although the amino acid sequence of the horse 
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Fig.2. Nucleotide sequence of Na,K-ATPase LYI subunit gene. Lengths of introns are shown in parentheses. 
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2288-2337 aAA..........intron 16 (0.16kb) . . . . . . . . ..AAMTATITFGCCTXCTAG GT.CGT.CTG.ATC.TR.GAT.AAC.TI'G.AAG.AAA.WC.ATT.GCC.TAC.ACC.CTG.ACC 
~Glly-Arg-Leu-Ile-Phc-A~p-A~n-Ly.-Ly~-~y~-S~r-Ile-Ala-~r-~~-~U-~r 
2434-2469 ACA.GAC.AX.GTAAmATGTCGAGCTTCCA..........intrOn 17 (0.36kb) . . . . . . . . ..CrrGCCGCCCCTACCCCC).Grr.rrC.GCC.Irr.rrC.C 
Thr-Asp-Met ml-Pro-Ala-Ilc-SW-Leu-AlA-Tyr-Glu 
2470-2565 CAI\.GCT.GAG.AGC.GAC.A~.A~.MG.AGA.CAG.CCC.AGA.MC.CCC.CAG.ACG.GAC.~.~.~.MT.Gffi.~.~.A~.~.A~.~.TAC.ffiA.~.A~ 
Gln-Ala-Glu-Ser-Asp-Ile-net-LyS-Arq-Gln-P~~-Arq-A~"-PrO-Gln-~r-A~p-Ly~-~"-V~l-A~n-GlU-Arg-~U-Il~-S~~-~~t-Al~-~r-Gly~l~-Il~ 
2566-2601 G GTGAGCTGCCACATGGCGlY..........intron IS (1.30kb)..........Tl'ACTl'TETAACTICTT AG GT.ATG.ATC.CAG.GCC.CTA.GGG.m.TFC.ACC 
Gily) ~G)ly-"et-Ilc-Gln-AlA-Leu-Gly-Gly-Phe-Phe-Tbr-Tyr 
X02-2697 m.Gni.AlTI'.~.~.GAG.MT.GGC.TPC.Crr. 
Phe-Val-Ile-Leu-Ala-G1u-Aisn-Gly-Phe-Leu-Pro-Ile-Hiw-Leu-Leu-Gly-Leu-Arg-V~l-A~p-hp-Aap-A~p-Arg-Tr~V~l-A8n-A~~Val-Glu-A~p-Ser 
X98-2733 TAC.C&G.CAG.CAG.TGG.GTGAG~AGCWCTCAGTIC..........lntr0" 19 (O.OQkb).......... TT+lWX~G.A.TAC.GM.CAG.~.AAA.A= 
Tyr-Gly-Cl"-Gin-Trp Thr-Tyr-Glu-Gln-Arg-Lys-Ile 
2734-2829 G'FG.GAG.m.ACC.TGC.CAC.ACA.GCA.~.~.G~.AGT.A~.~.G~.GTA.CAG.~.~C.GAC.~.~.A~.~.~.A~.~.~.~.~.~.~ 
Val-G1~-Phe-Thr-Cys-Hi.-Thr-l\la-Phe-Phe-V~l-Se~-Il~-Val-V~l-V~l-Gl~-Trp-Al~-A~p-~~-V~l-Il~-Cy~-Lys-~r-~g-~g-A~~-Ser-VAl-Phe 
2810-2865 0.G.CAG.GGG.ATG.M GTGTAAAGGACAGTCAGGTT . . . . . . . . ..intron 20 (0.35kb)..........m CTIGACPFFAG G.AAC.AAG.ATC.~A.ATA.Tl'l'.GGC 
Gin-Gin-Gly-Met-Ly(s) (LyJs-Am-Lym-Ile-Leu-Ile-Phe-Gly 
2866-2945 CTC.m.G~.GI\G.ACG.GCC.C~.GCT.GCC.~.~.~C.TAC.~.Cff.~A.A~.~.~.~.~.~.A~.TAT.~.~.~ CT-CA'XCEECUC.. 
Leu-Phe-Glu-Glu-Thr-al~-L~~-Al~-Al~-Ph~-L~~-S~r-~r-Cy~-Pr~-Gly-~~t-Gly-"~I-Al~-~~-~g-~~t-~r-~~-~~-Ly~~, 
2Q,6-3000 . . . . . . ..intron 21 (2.17kb)..........GGTACCTG CTITITCCAG G.CCT.ACC.TGG.'lW.T.TGT.GCC.TlY.CCG.TAC.~.'ZIT.~.A'F2.TTC.GTG.?AT.GAC 
(Ly)s-Pro-~r-Trp-Trp-Phe-Cy.-Ala-Ph.-Ph~-Pr~-~r-~r-~"-~"-Ila-Phe-V~l-~r-A8p 
X001-3039 GAA.GTC.AGA.AAA.CW.ATC.A'IC.AGG.CGA.CGC.CCT.GGC.G GTAATTACAGGCATTlTAGC..........intron 12 (0.53kb) . . . . . . . . ..CAG GC 
Gl"-Val-Airq-LyS-Le"-Ile-Ile-nrq-Arg-Arg-PrO-Gly-G~ly~ (Glly 
,O,O-,159 TCG.GTC.GAG.MG.GAG.ACC.TACC.TAC.TAG.ACGCCA~~A~C~GG~~G~ACC~CCC~A~~CC~C~A~ ~ClFl@ACCCTG 
ENb (3063, Trp-Val-Gl"-Lys-Gl"-Thr-Tyr-Tyr-Tyr-g~= 
3160-3288 GTAGG-ACCGAAGCATGTGGGGG MGCCAGACGKCCUjUn;MCCA~TA*ATA~A~~~-CRAVAT 
3289-3417 GTGCCTR7TGTWTl'C T-U;ATMCTr~-A~-~TACA~ATA-A~A-T~~-A~AT~-~--~~ 
3418-3546 TCCAGA~KTClrCTGTFG'~A~A~~~~AC~ ACAGTCCCCAGCC'XGAGACAGG~--maACB 
3517-3569 AXn;AGCCAMCAGGTGGTCCC 
enzyme protein has not been determined, the N- 
terminal 5 amino acids might be cleaved off post- 
translationally as observed in other Na,K- 
ATPases. The mature protein would then consist 
of 1016 amino acids and its A4, would be 112264. 
The amino acid sequence of horse LYI deduced from 
the exons has the homology values of rat (~1 [2] 
95.8%, human CYI [4] 97.5070, sheep ~1 [5] 97.0070, 
pig LYI [6] 97.5070, chicken a~1 [7] 93.8070, Torpedo 
al [8] 86.29’0, rat LYZ [l] 87.2% and rat LYJ [l] 85.6% 
(fig.3). The horse gene obtained here was proved 
to correspond to the a~1 subunit gene on the basis 
of the extensive homology of nucleotide and amino 
acid sequences with those of al from other species, 
but not those of (~2, cy3 or any other isoforms. 
Eight transmembrane segments have been 
predicted [5] from hydrophobicity. Transmem- 
brane segments Ml, M2, M3, M5, M7 and M8 [5] 
were located within the exons 4, 5, 8, 17, 20 and 
21, respectively, but M4 and M6 were interrupted 
by intron 8 and intron 18, respectively (fig.1 and 
fig.2). Extensive similarities were observed in ex- 
ons containing the site of phosphorylation [34] in 
exon 9, the FITC-binding site [35] in exon 12, the 
FSBA-binding site [36] in exon 16, and in addition, 
the transmembrane segments and extracellular do- 
mains [5] show high homology. These essential 
segments with important physiological functions 
and the organization of membrane folding are 
common in most species. Variable sequences occur 
rather non-randomly in exons 10, 12, and 13 and 
exon 19, all of which are on the cytoplasmic side. 
Variability of the N-terminus is distinct. The 
amino acid sequence of horse LYI is the most 
homologous to human cyl and among the 26 dif- 
ferent amino acids, 11 are located in the N- 
terminal intracellular portion. 
113Arg and 124Asp at the Ml-M2 junction of 
rat al are uniquely different from those of the 
ouabain-sensitive enzyme species. These dif- 
ferences were suggested to be responsible for the 
ouabain insensitivity [37]. The horse kidney en- 
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Fig.3. Comparison of amino acid sequences of Na,K-ATPase subunits in various species. Positions of introns are indicated by the 
following symbols: class 0 introns [39] interrupting the reading phase between codons, arrow; class I introns between the first and 
second nucleotides of the triplet, white arrowhead; and class II introns between the second and third nucleotides, black arrowhead. 
The Ml-M8 membrane spanning regions [5] are indicated above the sequence. Gaps are introduced to optimize alignment. 
zyme is highly sensitive to ouabain [21] and its 
amino acids, 1llGln and 122Asn (numbers cor- 
responding to 113Arg and 124Asp of rat (~1 [2], 
respectively) are the same as those of other sen- 
sitive species. Although the Ml-M2 junction is 
thus related to the ouabain-binding site, it is not 
clear whether this sequence difference wholly ac- 
counts for the insensitivity or not. There is a report 
that has confirmed the internalization of ouabain 
[38]. The possibility that the receptor itself is 
located on the intracellular side and that the 
Ml-M2 hydrophobic domain only works as a 
modulator for ouabain binding cannot be ruled 
out. 
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